CSIMarket
 
Invo Bioscience Inc   (INVO)
Other Ticker:  
 

Invo Bioscience Inc

Business Description


Invo Bioscience Inc is a medical device company that focuses on infertility treatments. The company was founded in 2007 and is headquartered in Medford, Massachusetts.

The main product offered by Invo Bioscience is the INVOcell, which is an innovative medical device that is used in the process of in vitro fertilization (IVF). IVF is a fertility treatment technique where eggs are fertilized by sperm outside of the body and then implanted into the uterus. The INVOcell device is different from traditional IVF as it allows for a more natural and patient-friendly approach.

The INVOcell device consists of a small, cylindrical chamber that is made of medical-grade plastic and holds the eggs and sperm during the fertilization process. The device is placed directly into the woman*s vagina, where it remains for several days. This allows for the development of the fertilized embryos within the woman*s own body, in a manner that is more in line with natural conception.

One of the main advantages of the INVOcell system is its simplicity. Traditional IVF requires highly specialized laboratory equipment and an extensive team of scientists, while the INVOcell system can be administered by a smaller team of healthcare professionals, making it more accessible and cost-effective.

Another advantage of the INVOcell system is its lower medication requirements. Traditional IVF often requires high doses of fertility medications to stimulate egg production, while the INVOcell system requires fewer medications, reducing the potential side effects and costs associated with hormonal treatments.

Invo Bioscience provides comprehensive training and support to fertility clinics that wish to offer the INVOcell system to their patients. The company also offers a range of ancillary products and services to support the successful implementation of the INVOcell system.

In terms of regulatory approval, the INVOcell system has received clearance from the U.S. Food and Drug Administration (FDA) and is also approved in several international markets.

Invo Bioscience is led by a team of experienced executives and scientists who are dedicated to advancing reproductive technology and improving outcomes for patients struggling with infertility. The company is actively involved in ongoing research and development to further enhance the INVOcell system and explore new applications for its technology.

In summary, Invo Bioscience Inc is a medical device company specializing in infertility treatments. Its flagship product, the INVOcell system, offers a more natural and patient-friendly approach to IVF, with advantages such as simplicity, reduced medication requirements, and lower costs. The company provides comprehensive support to fertility clinics and is committed to advancing reproductive technology.



View Company Supplier View Company Competition View Company Customers


Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com